Epidemiological studies have linked dirty air to dementia and other brain disorders. Now researchers are trying to determine ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...

An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated both as ...

Annovis Bio (ANVS) announced it was granted the U.S. patent covering methods for the treatment and prevention of acute brain or nerve injuries ...

University at Buffalo researchers reveal molecular insights into the neurotoxic effects of PFAS. Per- and polyfluorinated ...

Annovis Bio, headquartered in Malvern, Pennsylvania, is committed to addressing neurodegeneration in diseases such as Alzheimer's and Parkinson's. The company is developing innovative therapies that ...

During a Case-Based Roundtable® event, Rahul Banerjee, MD, discussed approaches to dosing and tolerability when using ...

Researchers sought to determine whether CNS bridging radiotherapy would improve responses to CAR-T therapy in patients with B-cell lymphomas.

The study is particularly significant because it could help explain the association between these plastic-derived chemicals ...

Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering ...

In a recent study, researchers from Uppsala University have shown that the Semliki Forest virus enters the central nervous ...

Home cooks, listen up! It might be time for a kitchen utensil overhaul. A new study found that black-colored plastic — common ...